MedPath

A prospective randomized controlled study of the efficacy of tetramethylpyrazine combined with Bupi Yishen Heat-sensitive Moxibustion on chronic kidney disease stages1-3

Not Applicable
Recruiting
Conditions
chronic kidney disease
Registration Number
ITMCTR2200006598
Lead Sponsor
Jiujiang Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

?patients with chronic kidney disease and CKD1-3 stage (GFR = 30 mL / min),
?patients with spleen-kidney yang deficiency and blood stasis syndrome,
?patients aged between 18 and 65 years old,
?patients who were willing to take part in the test and sign the informed consent form.

Exclusion Criteria

?mentally ill patient who do not sign the informed consent form
?life-threatening diseases of other systems
?patients who are subject to relevant treatment that may affect the effect of this test,
?patients with other organ failure who have obvious bleeding
?pregnant or lactating women or patients with excessive menstruation,
?patients with allergies and allergies to multiple drugs,
?coma patients, sensory disorders, and advanced tumor patients,
?patients with hematological diseases, skin ulcers or lesions.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
estimated glomerular filtration rate;serum creatinine;
Secondary Outcome Measures
NameTimeMethod
Cystain;24-hour urine protein;ß2-microglobulin;blood urea nitrogen;Fibrinogen;hemoglobin;red blood cell;plasma albumin;
© Copyright 2025. All Rights Reserved by MedPath